| Issue | Title | |
| Vol 22, No 1 (2021) | A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel | Abstract HTML PDF |
| Cristian Scatena, Roberto Ravasio, Paola Raimondo, Mario Giuliano | ||
| Vol 13, No 1 (2012) | A changing journal in a changing health care | Details HTML PDF |
| Mario Eandi | ||
| Vol 18, No 1 (2017) | A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context | Abstract HTML PDF |
| Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero | ||
| Vol 14, No 4 (2013) | A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations | Abstract HTML PDF |
| Marco Bellone, Pierluigi Sbarra | ||
| Vol 18, No 1 (2017) | A general model for the estimation of societal costs of lost production and informal care in Italy | Abstract HTML PDF |
| Lorenzo Pradelli, Gianni Ghetti | ||
| Vol 15, No 3 (2014) | A new decision model for economic evaluation of novel therapies for HCV | Abstract HTML PDF |
| Matteo Ruggeri, Americo Cicchetti, Silvia Coretti, Carlo Cammà, Nicola Caporaso, Antonio Gasbarrini | ||
| Vol 14, No 1 (2013) | A pharmacoeconomic analysis of the use of single MMC instillation in low risk NMIBC in Italy | Abstract HTML PDF |
| Renzo Colombo, Federico Pellucchi, Lorenzo Rocchini, Carmen Maccagnano, Pablo Katz, Valeria Pegoraro | ||
| Vol 13, No 2S (2012) | Abruzzo | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Abruzzo | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 13, No 1 (2012) | Access to pharmaceutical products in six European countries – analysis of different pharmaceutical distribution systems | Abstract HTML PDF |
| Evelyn Walter, Aline Dragosits, Monira Said | ||
| Vol 18, No 1 (2017) | Acknowledgement to reviewers (January - December 2017) | Details PDF |
| Ombretta Bandi | ||
| Vol 19, No 1 (2018) | Acknowledgement to Reviewers (January - December 2018) | Details HTML PDF |
| Ombretta Bandi | ||
| Vol 6, No 4 (2005) | Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico | Abstract PDF |
| Lorenzo Pradelli, Mario Eandi | ||
| Vol 12, No 2S (2011) | Aderenza e persistenza: due elementi chiave per la determinazione dell’efficacia terapeutica in usual care | Details PDF |
| Giampiero Mazzaglia, Ovidio Brignoli, Achille P. Caputi, Claudio Cricelli | ||
| Vol 13, No 1 (2012) | Adherence to therapeutic guidelines among patients treated with statins. Results from STAR study | Abstract HTML PDF |
| Luca Degli Esposti, Diego Sangiorgi, Gabriele Lazzeri, Stefano Buda | ||
| Vol 12, No 2 (2011) | Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population | Abstract HTML PDF |
| Luca Degli Esposti, Diego Sangiorgi, Giuseppe Di Pasquale, Gian Franco Gensini, Ido Iori, Stefano Buda, Ezio Degli Esposti | ||
| Vol 19, No 1 (2018) | Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model | Abstract HTML PDF |
| Lorenzo Pradelli, Sara Villa, Giancarlo Castaman | ||
| Vol 3, No 1 (2002) | ALPRAZOLAM: profilo farmacoeconomico nei disturbi d’ansia e da attacchi di panico | Abstract PDF |
| Mario Eandi | ||
| Vol 20, No 1S (2019) | An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West | Abstract HTML PDF |
| Giancarlo Casolo, Giuseppe Cavirani, Alessandro Del Carlo, Sergio Iannazzo, Massimo Pardini, Alessandro Squillace | ||
| Vol 1, No 2 (2000) | Analisi comparativa del mercato dei dispositivi per incontinenza in cinque paesi europei | Abstract PDF |
| Dante Cornago, Livio Garattini | ||
| Vol 6, No 4 (2005) | Analisi costi-efficacia di 90Y-ibritumomab tiuxetano (Zevalin®) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato | Abstract PDF |
| Carlo Lazzaro, Manolo Beelke | ||
| Vol 5, No 2 (2004) | Analisi Costo Minimizzazione delle preparazioni di Interferon Beta per il trattamento della Sclerosi Multipla | Abstract PDF |
| Francesco Macchia, Pierluigi Russo, Luciano Caprino | ||
| Vol 3, No 2 (2002) | Analisi costo/efficacia della doxofillina vs. teofillina nella terapia dell’asma cronica reversibile dell’adulto | Abstract PDF |
| Mario Eandi, Elisa Berno, Lorenzo Pradelli | ||
| Vol 5, No 4 (2004) | Analisi costo/efficacia di sevelamer nel trattamento dell’iperfosforemia del paziente in dialisi | Abstract PDF |
| Mario Eandi, Nicola Giotta, Gaia Santagostino Barbone | ||
| Vol 6, No 4 (2005) | Analisi Costo-Efficacia di Amfotericina B Liposomiale (L-AmB) versus Amfotericina B Complesso Lipidico (ABLC) nel trattamento empirico della neutropenia febbrile | Abstract PDF |
| Mario Eandi | ||
| Vol 4, No 4 (2003) | Analisi dei costi di buprenorfina vs metadone nella terapia dei soggetti con dipendenza da oppiacei | Abstract PDF |
| Giorgio L. Colombo, Guido Faillace, Michele Ferdico | ||
| Vol 3, No 3 (2002) | Analisi della persistenza e delle risorse allocate nel trattamento farmacologico dell’ipertensione arteriosa | Abstract PDF |
| Luca Degli Esposti, Alessandro Capone, Ezio Degli Esposti, Giorgio Valpiani, Mirko Di Martino, Gianluca Baio, Pierluigi Russo, Stefano Buda, Alessandra Sturani, Luciano Caprino | ||
| Vol 6, No 2 (2005) | Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule | Abstract PDF |
| Roberto Ravasio | ||
| Vol 6, No 4 (2005) | Analisi di costo efficacia nella terapia della BPCO | Abstract PDF |
| Sergio Iannazzo, Lorenzo Pradelli, Roberto W. Dal Negro, Mario Eandi | ||
| Vol 5, No 4 (2004) | Analisi di minimizzazione dei costi del trattamento della leucemia cronica con fludarabina fosfato (Fludara®) e.v. e p.o.: metodologia e risultati di un’indagine empirica | Abstract PDF |
| Carlo Lazzaro | ||
| Vol 6, No 2 (2005) | Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale | Abstract PDF |
| Felice Vadruccio, Giovanni Biricolti, Leonardo Mendolicchio | ||
| Vol 21, No 1 (2020) | Analysis of Market Access Agreements in Turkey | Abstract HTML PDF |
| Guvenc Kockaya, Okan Atalay, Mustafa Kurnaz, Selin Okcun, Nazlı Sencan, Cigdem Gedik, Mete Saylan, Gulpembe Oguzhan | ||
| Vol 17, No 1 (2016) | Analysis of the treatment cost of HIV/AIDS in Turkey | Abstract HTML PDF |
| Guvenc Kockaya, Tuba Elbir Zengin, Fatma Betul Yenilmez, Canan Dalgic, Simten Malhan Simten Malhan, Pamir Cerci, Ergun Oksuz, Serhat Unal | ||
| Vol 11, No 2 (2010) | Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept | Abstract PDF |
| Viola Sacchi, Orietta Zaniolo, Ignazio Olivieri | ||
| Vol 9, No 1S (2008) | Appendice | Details PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 3, No 2 (2002) | Appropriatezza clinica ed economica: strumenti e modelli di valutazione e gestione dell’attività psichiatrica | Abstract PDF |
| Carmine Munizza, Salvatore Nieddu, Maurizio Bianco | ||
| Vol 23, No 1 (2022) | Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis | Abstract HTML PDF |
| Francesco Mennini, Daniele Rossi, Andrea Marcellusi | ||
| Vol 13, No 3 (2012) | Assessment of the innovative quality of agomelatine through the Innovation Assessment Algorithm | Abstract HTML PDF |
| Liliana Civalleri, Sabrina Licata | ||
| Vol 8, No 2 (2007) | Asthma and public awareness in Italy: results from CHAOS (Chronic Airway Obstruction Survey) | Abstract PDF |
| Stefano Uleri, Roberto W. Dal Negro | ||
| Vol 8, No 1S (2007) | Atti del I Convegno. Laboratorio dose unitaria Galenica clinica e gestione del rischio: modelli ed esperienze | Details PDF |
| Alessandro D’Arpino, Francesca Venturini, Luigi Giuliani, Ilario Viano, Oscar Alabiso, Massimo Boni, Maria Rachele Chiappetta, Stefano Federici, Franca Goffredo, Antonella Cannas, Paolo Serra | ||
| Vol 2, No 4 (2001) | Automedicazione: una risorsa economica da valorizzare | Abstract |
| Carlo Lucioni, Luca Zappaterra | ||
| Vol 13, No 2S (2012) | Basilicata | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Basilicata | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 8, No 1 (2007) | Bayesian statistic methods and theri application in probabilistic simulation models | Abstract PDF |
| Sergio Iannazzo | ||
| Vol 7, No 1 (2006) | Bayesian statistic methods and theri application in probabilistic simulation models | Abstract PDF |
| Orietta Zaniolo, Mario Eandi | ||
| Vol 13, No 2S (2012) | Bolzano | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Bolzano | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 17, No 3 (2016) | Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy | Abstract HTML PDF |
| Marco Bellone, Roberto Di Virgilio, Paolo Di Rienzo | ||
| Vol 15, No 1S (2014) | Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients | Abstract HTML PDF |
| Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro | ||
| Vol 18, No 1 (2017) | Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation | Abstract HTML PDF |
| Maria Grazia Celeste, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, Roberto Ravasio | ||
| Vol 18, No 1 (2017) | Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients | Abstract HTML PDF |
| Francesco Mennini, Andrea Marcellusi, Raffaella Viti, Giuseppe Saglio | ||
| Vol 17, No 1 (2016) | Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients | Abstract HTML PDF |
| Umberto Restelli, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, Davide Croce | ||
| Vol 10, No 1 (2009) | Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy | Abstract PDF |
| Francesco Bamfi, Federica Basso, Massimo Aglietta, Carmelo Bengala, Vito Lorusso, Paolo Pronzato, Maria Caterina Cavallo, Orietta Zaniolo, Sergio Iannazzo | ||
| Vol 15, No 3 (2014) | Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease | Abstract HTML PDF |
| Valentina Lorenzoni, Giuseppe Turchetti | ||
| Vol 10, No 1 (2009) | Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy | Abstract PDF |
| Maurizio Benucci, Sergio Iannazzo, Luciano Sabadini | ||
| Vol 10, No 1 (2009) | Budget impact analysis of use of aliskiren in hypertension on the Italian Health Care System | Abstract PDF |
| Orietta Zaniolo, Lorenzo Pradelli | ||
| Vol 13, No 3 (2012) | Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy | Abstract HTML PDF |
| Francesco Mennini, Sergio Russo, Andrea Marcellusi | ||
| Vol 8, No 1 (2007) | Budget impact of rosiglitazone in type 2 diabetes | Abstract PDF |
| Orietta Zaniolo, Francesco Bamfi, Sergio Iannazzo | ||
| Vol 9, No 3 (2008) | Budget impact of vildagliptin | Abstract PDF |
| Orietta Zaniolo, Viola Sacchi, Lorenzo Pradelli | ||
| Vol 23, No 1 (2022) | Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy | Abstract HTML PDF |
| Patrizia Berto, Marco Bellone, Alice Sabinot, Carmine Pinto, Massimo Martino, Daniele Generali, Pier Luigi Carriero, Maria Domenica Sanna | ||
| Vol 13, No 2S (2012) | Calabria | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Calabria | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 13, No 2S (2012) | Campania | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Campania | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 14, No 1 (2013) | Can market structure explain cross-country differences in health? | Abstract HTML PDF |
| Kate Rybczynski, Lori Curtis | ||
| Vol 13, No 1S (2012) | Cetuximab in first line treatment of metastatic colorectal cancer | Abstract HTML PDF |
| Carlo Barone, Andrea Belisari, Fortunato Ciardiello, Lorenzo Mantovani, Lucia D’Angiolella, Gianluca Furneri, Nicola Normanno, Patrizio Piacentini, Carmine Pinto | ||
| Vol 13, No 1 (2012) | Clinical and economic impact of aliskiren in uncontrolled hypertensive patients | Abstract HTML PDF |
| Ezio Degli Esposti, Radovan Tomic | ||
| Vol 12, No 2 (2011) | Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection | Abstract HTML PDF |
| Mario Eandi | ||
| Vol 13, No 3 (2012) | Clinical and economic profile of prucalopride in the treatment of chronic constipation in women | Abstract HTML PDF |
| Vincenzo Stanghellini, Mario Eandi | ||
| Vol 21, No 1S (2020) | Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes | Abstract HTML PDF |
| Edoardo Mannucci, Pier Paolo Mangia, Lorenzo Pradelli | ||
| Vol 7, No 3 (2006) | Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases | Abstract PDF |
| Orietta Zaniolo | ||
| Vol 11, No 1 (2010) | Clinical and pharmacoeconomic profile of lanthanum carbonate treatment of hyperphosphataemia in chronic renal dialysis patients | Abstract PDF |
| Mario Eandi | ||
| Vol 21, No 1 (2020) | Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer | Abstract HTML PDF |
| Giovanni Gancitano, Roberto Ravasio, Lorenzo Cattelino, Paolo Di Procolo, Diego Cortinovis | ||
| Vol 4, No 2 (2003) | Commenti al lavoro di Colombo GL, Muzio A “Gli inibitori di pompa protonica nelle patologie acido-correlate: il ruolo di rabeprazolo in una strategia di cost minimisation” | Details PDF |
| Cristina Rossi, Giancarlo Benelli | ||
| Vol 6, No 3 (2005) | Commenti all’articolo: “Interruzione del trattamento nei pazienti con schizofrenia che ricevono olanzapina o aripiprazolo: metanalisi degli studi clinici controllati” | Details PDF |
| Giovanni Battista Leproux, Michele Intorcia | ||
| Vol 15, No 1S (2014) | Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients | Abstract HTML PDF |
| Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro | ||
| Vol 16, No 3 (2015) | Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US | Abstract HTML PDF |
| Massimiliano Povero, Lorenzo Pradelli | ||
| Vol 16, No 1S (2015) | Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis | Abstract HTML PDF |
| Massimiliano Povero, Lorenzo Pradelli | ||
| Vol 4, No 3 (2003) | Considerazioni cliniche ed economiche nel trattamento del cancro della prostata: analisi costo-efficacia di bicalutamide vs flutamide in combinazione con LHRH | Abstract PDF |
| Monia Marchetti, Giorgio Lorenzo Colombo | ||
| Vol 13, No 2 (2012) | Consumer preferences for the predictive genetic tests for Alzheimer’s disease | Abstract HTML PDF |
| Ming-Yi Huang, Matthew Perri III | ||
| Vol 21, No 1 (2020) | Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/1 | Abstract HTML PDF |
| [No authors listed] | ||
| Vol 21, No 1 (2020) | Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/2 | Abstract HTML PDF |
| [No authors listed] | ||
| Vol 20, No 1 (2019) | Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs | Abstract HTML PDF |
| [No authors listed] | ||
| Vol 16, No 2 (2015) | Cost analysis of inappropriate treatments for suspected dermatomycoses | Abstract HTML PDF |
| Emanuela Fiammenghi, Angela Patalano, Viviana Lo Conte, Gabriella Calabrò | ||
| Vol 16, No 1 (2015) | Cost differentials of dental outpatient care across clinical dentistry branches | Abstract HTML PDF |
| Jovana Rančić, Nemanja Rančić, Nemanja Majstorović, Vladimir Biočanin, Marko Milosavljević, Mihajlo Jakovljević | ||
| Vol 20, No 1 (2019) | Cost Minimization Analysis of Radiofrequency Compared to Laser Thermal Ablation in Patients with Hepatocellular Carcinoma | Abstract HTML PDF |
| Maria Guarino, Lucia Sara D'Angiolella, Luigia Falco, Federica Morando, Giovan Giuseppe Di Costanzo, Filomena Morisco, Giovanni Improta, Lorenzo Giovanni Mantovani, Nicola Caporaso | ||
| Vol 17, No 2 (2016) | Cost of care of chronic non-communicable diseases in Jamaican patients: the role of obesity | Abstract HTML PDF |
| Christine M. Fray-Aiken, Rainford J. Wilks, Abdullahi O. Abdulkadri, Affette M. McCaw-Binns | ||
| Vol 16, No 3 (2015) | Cost of illness of advanced ovarian carcinoma in Italy: results of an empirical, single-centre study | Abstract HTML PDF |
| Carlo Lazzaro, Francesco Plotti, Stella Capriglione, Matteo Ferrario, Roberto Angioli | ||
| Vol 13, No 3 (2012) | Cost of illness of community-acquired pneumonia. Review of the literature and possible strategies in the Serbian health care setting | Abstract HTML PDF |
| Mihajlo Jakovljevic, Vojislav Cupurdija, Zorica Lazic | ||
| Vol 12, No 3 (2011) | Cost of osteoporosis-related fracture in Italy. Results of the BLOCK study | Abstract HTML PDF |
| Luca Degli Esposti, Silvano Adami, Giovanni Iolascon, Alfredo Nardi, Luca Pietrogrande, Giuseppina Resmini, Maurizio Rossini, Umberto Tarantino, Paolo Tranquilli Leali, Carlo Trevisan, Alessandra Cheli, Chiara Veronesi, Stefano Buda | ||
| Vol 11, No 2 (2010) | Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes | Abstract PDF |
| Simona Cammarota, Enrica Menditto, Daria Putignano, Anna Citarella | ||
| Vol 11, No 2 (2010) | Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy | Abstract PDF |
| Orietta Zaniolo, Sorrel E. Wolowacz, Lorenzo Pradelli | ||
| Vol 19, No 1 (2018) | Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer | Abstract HTML PDF |
| Giovanni Gancitano, Roberto Ravasio, Matteo Dionisi, Diego Cortinovis | ||
| Vol 22, No 1 (2021) | Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy | Abstract HTML PDF |
| Massimiliano Povero, Lorenzo Pradelli, Andrea Serra, Francesca Fanelli, Luca Gazzi | ||
| Vol 20, No 1 (2019) | Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective | Abstract HTML PDF |
| Lorenzo Giovanni Mantovani, Gianluca Furneri, Rossella Bitonti, Paolo Cortesi, Elisa Puma, Laura Santoni, Luca Prosperini | ||
| Vol 18, No 1 (2017) | Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study | Abstract HTML PDF |
| Sergio Iannazzo, Edoardo Mannucci, Odette Reifsnider, Aldo Pietro Maggioni | ||
| Vol 7, No 2 (2006) | Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer | Abstract PDF |
| Mario Eandi | ||
| Vol 19, No 1 (2018) | Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis | Details HTML PDF |
| Diego Centonze, Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Luigi Giuliani, Pier Luigi Canonico | ||
| Vol 12, No 2 (2011) | Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice | Abstract HTML PDF |
| Orietta Zaniolo, Sergio Iannazzo, Gian Piero Patrucco, Roberto Bellini | ||
| Vol 23, No 1 (2022) | Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy | Abstract HTML PDF |
| Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Alessandra Cardillo, Laura Santoni, Luca Prosperini | ||
| 1 - 100 of 481 Items | 1 2 3 4 5 > >> | |
User
Font Size